German pharmaceutical company BioNTech is confident that its coronavirus vaccine works against the new UK variant, but further studies are need to be completely sure, its chief executive Ugur Sahin said Tuesday.

Mr Sahin said that the proteins on the UK variant are 99 per cent the same as on the prevailing strains, and therefore BioNTech has "scientific confidence" that its vaccine will be effective.

Read the full story here: https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-covid-tier-4-christmas-lockdown-uk-strain-deaths/

Subscribe to The Telegraph on YouTube ► https://bit.ly/3idrdLH

Get the latest headlines: https://www.telegraph.co.uk/

Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK's best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture.